LIDOCAINE | A080198 | FOUGERA PHARMACEUTICALS INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Quagen Pharmaceuticals LLC FDA-2017-P-5080 Quagen Pharmaceuticals LLC filed this citizen petition under section 505(j) of the Federal Food, Drug, and Cosmetic Act requesting that the FDA designate Lidocaine Ointment 5% manufactured by Fougera Pharmaceuticals Inc (ANDA 080198) as a Reference Listed Drug in the Orange Book. The petitioner seek | Other | 2017-08-22 | Withdrawn | Quagen Pharmaceuticals LLC |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.